X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tavaborole (38) 38
onychomycosis (32) 32
index medicus (25) 25
efinaconazole (22) 22
humans (16) 16
dermatology (15) 15
onychomycosis - drug therapy (15) 15
terbinafine (15) 15
pharmacology & pharmacy (14) 14
toenail onychomycosis (14) 14
ciclopirox (12) 12
administration, topical (11) 11
antifungal agents (11) 11
antifungal agents - therapeutic use (11) 11
fluconazole (10) 10
itraconazole (10) 10
prevalence (10) 10
epidemiology (9) 9
antifungal agent (7) 7
antifungal agents - administration & dosage (7) 7
surgery (7) 7
animals (6) 6
antifungal (6) 6
drug therapy (6) 6
luliconazole (6) 6
mycoses (6) 6
nail (6) 6
trichophyton-rubrum (6) 6
antifungal agents - adverse effects (5) 5
antifungal agents - pharmacology (5) 5
boron compounds - therapeutic use (5) 5
bridged bicyclo compounds, heterocyclic - therapeutic use (5) 5
efficacy (5) 5
photodynamic therapy (5) 5
topical solution (5) 5
treatment outcome (5) 5
amorolfine (4) 4
antifungal activity (4) 4
biochemistry & molecular biology (4) 4
dermatophytes (4) 4
diagnosis (4) 4
dosage and administration (4) 4
dose-response relationship, drug (4) 4
female (4) 4
male (4) 4
microbiology (4) 4
nail lacquer (4) 4
pharmacokinetics (4) 4
safety (4) 4
therapy (4) 4
tinea pedis (4) 4
toxicology (4) 4
treating onychomycosis (4) 4
administration, cutaneous (3) 3
antifungal agents - toxicity (3) 3
boron compounds - administration & dosage (3) 3
boron compounds - toxicity (3) 3
bridged bicyclo compounds, heterocyclic - administration & dosage (3) 3
bridged bicyclo compounds, heterocyclic - toxicity (3) 3
care and treatment (3) 3
chemistry, medicinal (3) 3
clinical cure (3) 3
clinical trials (3) 3
complete cure (3) 3
double-blind (3) 3
drugs (3) 3
foot dermatoses - drug therapy (3) 3
fungal infections (3) 3
fungal nail infection (3) 3
fungi (3) 3
multicenter (3) 3
nail penetration (3) 3
oral terbinafine (3) 3
penetration (3) 3
pharmacology (3) 3
rats (3) 3
recurrence (3) 3
research (3) 3
susceptibility (3) 3
treatment (3) 3
trichophyton rubrum (3) 3
5-percent (2) 2
administration, oral (2) 2
adult (2) 2
aluminum-garnet laser (2) 2
analysis (2) 2
animals, newborn (2) 2
antifungal agents - chemistry (2) 2
antifungal agents - pharmacokinetics (2) 2
antifungals (2) 2
azoles (2) 2
booster therapy (2) 2
boron - therapeutic use (2) 2
boron - toxicity (2) 2
boron compounds - adverse effects (2) 2
bridged bicyclo compounds, heterocyclic - adverse effects (2) 2
candidiasis (2) 2
chemistry, multidisciplinary (2) 2
chemistry, organic (2) 2
children (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial agents and chemotherapy, ISSN 0066-4804, 07/2019, Volume 63, Issue 10
Onychomycosis is a nail fungal infection, mostly caused by dermatophytes. The treatment efficacy is impaired by difficulties of reaching effective drug levels... 
Trichophyton rubrum | DIAGNOSIS | VALIDATION | PENETRATION | TAVABOROLE | MICROBIOLOGY | antifungal resistance | ONYCHOMYCOSIS | ciclopirox | IN-VITRO | efinaconazole | transungual permeation | HUMAN NAIL | bovine hoof membranes | PHARMACOLOGY & PHARMACY | EPIDEMIOLOGY
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2018, Volume 62, Issue 12
The in vitro activity of tavaborole, an FDA-approved antifungal drug, was compared to that of four antifungal agents against 170 clinical fungal isolates... 
Tavaborole | Onychomycosis | Antifungal | DIAGNOSIS | NAIL PENETRATION | LULICONAZOLE | LANOCONAZOLE | BETA-TUBULIN GENE | EFINACONAZOLE | onychomycosis | MICROBIOLOGY | PREVALENCE | antifungal | RESISTANT | tavaborole | TRANSFER-RNA SYNTHETASE | PHARMACOLOGY & PHARMACY | EPIDEMIOLOGY
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 04/2019, Volume 80, Issue 4, pp. 853 - 867
Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophytes, and yeast, and is the most common nail disorder seen in clinical practice.... 
treatment | terbinafine | photodynamic therapy | plasma therapy | onychomycosis | clinical cure | itraconazole | complete cure | pulse dosing | lasers | ciclopirox | fluconazole | tavaborole | mycologic cure | booster therapy | efinaconazole | fungal nail infection
Journal Article
Journal Article
Journal of Dermatological Treatment, ISSN 0954-6634, 01/2018, Volume 29, Issue 1, pp. 44 - 48
Purpose: The role of topical antifungal agents in the long-term management of toenail onychomycosis is not well established. The current study evaluated... 
tinea unguium | tavaborole | AN-2690 | long-term follow-up | Antifungal agents | PREVALENCE | OUTCOMES | EPIDEMIOLOGY | DERMATOLOGY
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2018, Volume 62, Issue 1
ME1111 is a novel antifungal agent currently under clinical development as a topical onychomycosis treatment. A major challenge in the application of topical... 
ME1111 | Topical agent | Nail permeability | Dermatophyte | Onychomycosis | topical agent | NAIL PENETRATION | TOENAIL ONYCHOMYCOSIS | DRUG-DELIVERY | ANTIFUNGAL ACTIVITY | SUSCEPTIBILITY | CANDIDIASIS | onychomycosis | TAVABOROLE | MICROBIOLOGY | PREVALENCE | dermatophyte | THERAPY | PHARMACOLOGY & PHARMACY | nail permeability | FLUCONAZOLE
Journal Article
Advances in Skin & Wound Care, ISSN 1527-7941, 08/2019, Volume 32, Issue 8, pp. 350 - 357
GENERAL PURPOSETo provide information about the epidemiology, clinical features, and management of cutaneous tinea infections. TARGET AUDIENCEThis continuing... 
SURGERY | tinea | TOPICAL SOLUTION | CORPORIS | TOENAIL ONYCHOMYCOSIS | NURSING | case review | DERMATOPHYTOSES | GUIDELINES | TAVABOROLE | PREVALENCE | DERMATOLOGY | INCOGNITO | dermatophyte | fungal infection | fungi | cutaneous tinea infection | PEDIS | EPIDEMIOLOGY
Journal Article
Pediatric Dermatology, ISSN 0736-8046, 09/2018, Volume 35, Issue 5, pp. 552 - 559
Onychomycosis is an uncommon condition in childhood, but prevalence in children is increasing worldwide.The objective was to review the efficacy and safety of... 
oral therapy | onychomycosis | adverse events | topical therapy | children | TOENAIL ONYCHOMYCOSIS | EFINACONAZOLE | PENETRATION | TAVABOROLE | 10-WEEK-OLD INFANT | PREVALENCE | TINEA-PEDIS | DELIVERY | DERMATOLOGY | NAIL | PEDIATRICS | Mycoses | Drug approval | Onychomycosis | Antifungal agents | Pediatrics | Reviews | Children
Journal Article
Journal of Dermatological Treatment, ISSN 0954-6634, 01/2016, Volume 27, Issue 1, pp. 2 - 4
Journal Article
Journal Article
Expert Opinion on Drug Metabolism and Toxicology, ISSN 1742-5255, 04/2018, Volume 14, Issue 4, pp. 387 - 398
Journal Article
Journal Article
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, ISSN 1085-5629, 06/2015, Volume 34, Issue 3 Suppl, pp. S51 - S53
Historically, the eradication of onychomycosis has been a frustrating and often unsuccessful endeavor. However, new understanding about the mechanisms of... 
SURGERY | terbinafine | TOENAIL ONYCHOMYCOSIS | photodynamic therapy | LASER | Ciclopirox | onychomycosis | itraconazole | laser therapy | DELIVERY | DERMATOLOGY | TRICHOPHYTON-RUBRUM | fluconazole | tavaborole | NAIL | efinaconazole
Journal Article